Your session is about to expire
← Back to Search
Alpha-1 Blocker
Treatment for Erectile Dysfunction
N/A
Waitlist Available
Led By Allen D Seftel, MD
Research Sponsored by University Hospitals Cleveland Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial found that taking alfuzosin may improve sexual function in males who have both BPH and ED.
Eligible Conditions
- Erectile Dysfunction
- Benign Prostatic Hyperplasia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evaluate the medication on erection maintenance
Secondary outcome measures
Assess effect of Uroxatral on BPH and sexual function using questionnaires
Find a Location
Who is running the clinical trial?
University Hospitals Cleveland Medical CenterLead Sponsor
317 Previous Clinical Trials
340,251 Total Patients Enrolled
1 Trials studying Erectile Dysfunction
34 Patients Enrolled for Erectile Dysfunction
SanofiIndustry Sponsor
2,164 Previous Clinical Trials
3,514,974 Total Patients Enrolled
3 Trials studying Erectile Dysfunction
287 Patients Enrolled for Erectile Dysfunction
Allen D Seftel, MDPrincipal InvestigatorUniversity Urologists of Cleveland
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger